Education
About Us
Working with TipRanks
Follow Us
Cannapharmarx (CPMD)
:CPMD
CPMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume41.77K
Average Volume (3M)217.46K
Market Cap
$2.92M
Enterprise Value$23.56M
Total Cash (Recent Filing)-$3.66K
Total Debt (Recent Filing)$314.69K
Price to Earnings (P/E)―
Beta-4764.91
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding662,501,400
10 Day Avg. Volume406,105
30 Day Avg. Volume217,458
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap8.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-359.38
Enterprise Value/Ebitda-2.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Cannapharmarx News
PremiumCompany Announcements
Cannapharmarx Appoints Constantine Nkafu as Interim CEO
PremiumCompany Announcements
CannaPharmaRX Expands Cannabis Production and Profitability
PremiumCompany Announcements
CannaPharmaRx Achieves First Harvest Milestone
PremiumCompany Announcements
CannaPharmaRx Targets High Growth in 2023
PremiumCompany Announcements
CannaPharmaRx Expands to Latin America with ICAN
PremiumCompany Announcements
CannaPharmaRx Schedules Investor Update CallPremiumCompany Announcements
CannaPharmaRx Gains Key Certifications for Global Growth
PremiumCompany Announcements
CannaPharmaRx Welcomes Dean Medwid as CEO---
CPMD FAQ
What was Cannapharmarx ’s price range in the past 12 months?
Cannapharmarx lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Cannapharmarx ’s market cap?
Cannapharmarx ’s market cap is $2.92M.
When is Cannapharmarx ’s upcoming earnings report date?
Cannapharmarx ’s upcoming earnings report date is May 20, 2025 which is in 15 days.
How were Cannapharmarx ’s earnings last quarter?
Cannapharmarx released its earnings results on Aug 19, 2024. The company reported $0.008 earnings per share for the quarter, beating the consensus estimate of N/A by $0.008.
Is Cannapharmarx overvalued?
According to Wall Street analysts Cannapharmarx ’s price is currently Overvalued.
Does Cannapharmarx pay dividends?
Cannapharmarx does not currently pay dividends.
What is Cannapharmarx ’s EPS estimate?
Cannapharmarx ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannapharmarx have?
Cannapharmarx has 662,501,400 shares outstanding.
What happened to Cannapharmarx ’s price movement after its last earnings report?
Cannapharmarx reported an EPS of $0.008 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cannapharmarx ?
Currently, no hedge funds are holding shares in CPMD
---
Company Description
Cannapharmarx
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.
---
Applied DNA Sciences
―
Healthcare Triangle
―
Bluejay Diagnostics
―
Shuttle Pharmaceuticals Holdings, Inc.
―
---